• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Kardesoglu et al Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".

作者信息

Kardesoglu Ejder, Isilak Zafer, Yalcin Murat

机构信息

Gulhane Military Medical Academy, Haydarpasa Training Hospital, Department of Cardiology, Istanbul, Turkey.

出版信息

Circulation. 2016 Feb 9;133(6):e393. doi: 10.1161/CIRCULATIONAHA.115.018675.

DOI:10.1161/CIRCULATIONAHA.115.018675
PMID:26858299
Abstract
摘要

相似文献

1
Letter by Kardesoglu et al Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".卡尔德索格鲁等人就“冠状动脉旁路移植术后长期β受体阻滞剂治疗对长期预后二级预防的疗效”一文所写的信。
Circulation. 2016 Feb 9;133(6):e393. doi: 10.1161/CIRCULATIONAHA.115.018675.
2
Letter by Bergerot et al Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".伯杰罗等人就“冠状动脉旁路移植术后长期β受体阻滞剂治疗对长期预后的二级预防效果”一文所写的信。
Circulation. 2016 Feb 9;133(6):e392. doi: 10.1161/CIRCULATIONAHA.115.018316.
3
Letter by Poullis Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".普利关于文章《冠状动脉旁路移植术后长期β受体阻滞剂治疗对长期预后二级预防的疗效》的信函
Circulation. 2016 Feb 9;133(6):e391. doi: 10.1161/CIRCULATIONAHA.115.018190.
4
Response to Letters Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".对关于“冠状动脉旁路移植术后长期β受体阻滞剂治疗对长期预后的二级预防效果”一文的信件的回复
Circulation. 2016 Feb 9;133(6):e394-5. doi: 10.1161/CIRCULATIONAHA.115.019468.
5
Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.长期β受体阻滞剂治疗对冠状动脉旁路移植术后长期预后二级预防的疗效。
Circulation. 2015 Jun 23;131(25):2194-201. doi: 10.1161/CIRCULATIONAHA.114.014209. Epub 2015 Apr 23.
6
Efficacy of β-blocker therapy for secondary prevention for patients undergoing coronary artery bypass grafting surgery.β受体阻滞剂疗法对接受冠状动脉搭桥手术患者二级预防的疗效。
Curr Opin Cardiol. 2016 Nov;31(6):654-661. doi: 10.1097/HCO.0000000000000338.
7
Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice.冠状动脉旁路移植术后二级预防：一项全国随机对照试验的结果和持续的社会主导实践纳入。
Circulation. 2011 Jan 4;123(1):39-45. doi: 10.1161/CIRCULATIONAHA.110.981068. Epub 2010 Dec 20.
8
Effect of beta blockers after coronary artery bypass in postinfarct patients: what can we learn from available literature?β受体阻滞剂对心肌梗死后接受冠状动脉搭桥手术患者的影响：我们能从现有文献中学到什么？
Ann Thorac Surg. 2002 Nov;74(5):1727-32. doi: 10.1016/s0003-4975(02)03992-9.
9
Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.冠心病住院患者二级预防措施的时间趋势。
Am J Med. 2015 Apr;128(4):426.e1-9. doi: 10.1016/j.amjmed.2014.11.013. Epub 2014 Nov 26.
10
Acute myocardial infarction after Kawasaki disease in an infant: treatment with coronary artery bypass grafting.一名婴儿川崎病后发生急性心肌梗死：冠状动脉旁路移植术治疗
Pediatr Int. 2009 Jun;51(3):421-4. doi: 10.1111/j.1442-200X.2009.02830.x.